Company: PSTV
Filing Date: 2025-05-02
Form Type: 8-K
Source: 0000950170-25-062742
Chunk: 1

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-05-02
Form: 8-K
Item: Item 5.07
Chunk 1
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Special Meeting, the Company’s stockholders voted on Proposals 1 through 4, as described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 10, 2025 (the “ Proxy Statement”). Proposal 5, relating to the adjournment of the Special Meeting to solicit additional proxies, was not presented at the Special Meeting because a quorum was established and there were sufficient votes to approve the other proposals. Capitalized terms used but not defined herein shall have the meanings set forth in the Proxy Statement.

The Company had 11,785,078 shares of Common Stock issued and outstanding at the close of business on March 4, 2025, the record date for the Special Meeting. The holders of 8,175,799 shares of the Company’s issued and outstanding Common Stock were represented in person virtually or represented by valid proxy at the Special Meeting, constituting a quorum.

The vote results detailed below represent final results as certified by the inspector of elections.

Proposal No. 1 - Reverse Stock Split Proposal.

The Company’s stockholders granted discretionary authority to the Board to (i) amend the Company’s Certificate of Incorporation to combine outstanding shares of the Company’s Common Stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for twenty five (1-for-25) to a maximum of one-for-two hundred fifty (1-for-250), with the exact ratio to be determined by our Board in its sole discretion; and (ii) effect the reverse stock split, if at all, within twelve (12) months of the date the proposal is approved by stockholders. The votes regarding this proposal were as follows:

  Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────
  7,304,114            847,905           23,780                     0  

Proposal No. 2 - Issuance Proposal.

The Company’s stockholders authorized, for purposes of complying with Listing Rule 5635(d) of The Nasdaq Stock Market LLC (“ Nasdaq”), (1) the issuance of 28,042,138 Series A Warrants and 28,042,138 Series B Warrants issued in the Private Placement, (2) certain provisions of the Series A Warrants and Series B